High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma

dc.contributor.authorGarcia-Dios, D.
dc.contributor.authorLambrechts, D.
dc.contributor.authorCoenegrachts, L.
dc.contributor.authorVandenput, I.
dc.contributor.authorCapoen, A.
dc.contributor.authorWebb, P.
dc.contributor.authorFerguson, K.
dc.contributor.authorAnecs,
dc.contributor.authorAkslen, L.
dc.contributor.authorClaes, B.
dc.contributor.authorVergote, I.
dc.contributor.authorMoerman, P.
dc.contributor.authorVan Robays, J.
dc.contributor.authorMarcickiewicz, J.
dc.contributor.authorSalvesen, H.
dc.contributor.authorSpurdle, A.
dc.contributor.authorAmant, F.
dc.date.issued2013
dc.description.abstractAbstract not available
dc.description.statementofresponsibilityDiego A. Garcia-Dios, Diether Lambrechts, Lieve Coenegrachts, Ingrid Vandenput, An Capoen, Penelope M. Webb, Kaltin Ferguson, ANECS, Lars A. Akslen, Bart Claes, Ignace Vergote, Philippe Moerman, Johan Van Robays, Janusz Marcickiewicz, Helga B. Salvesen, Amanda B. Spurdle, Frédéric Amant
dc.identifier.citationGynecologic Oncology, 2013; 128(2):327-334
dc.identifier.doi10.1016/j.ygyno.2012.11.037
dc.identifier.issn0090-8258
dc.identifier.issn1095-6859
dc.identifier.urihttp://hdl.handle.net/2440/95511
dc.language.isoen
dc.publisherElsevier
dc.rightsCopyright © 2012 Elsevier Inc. All rights reserved.
dc.source.urihttps://doi.org/10.1016/j.ygyno.2012.11.037
dc.subjectEndometrial cancer
dc.subjectClinical molecular genetics
dc.subjectMolecular biomarkers
dc.subjectOncogenes
dc.subjectTumor suppressor genes
dc.titleHigh-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma
dc.typeJournal article
pubs.publication-statusPublished

Files